-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal
Giovanni Barosi
Drug Evaluation: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
AbobotulinumtoxinA for the treatment of upper limb spasticity
Wolfgang H Jost
Clinical Trail Outcomes: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
A focus on translational medicine is necessary to close the innovation gap in pharmaceutical medicine
Andreas WallnOfer
Editorial: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Clinical research in Latin America: obstacles and opportunities
Emmanuel Coronel, Donald Halstead, Felipe Fregni
Editorial: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation